Terminalia arjuna and Medicinal Properties: A Natural Product Source

Aayush K. Ramraje; Hemangi R. Patil; Bhupendra M. Mahale; Akshata M. Girase; Ghanshyam M. Chavan

doi:10.52711/0975-4385.2026.00059

Research Journal of Pharmacognosy and Phytochemistry

ISSN

0975-4385 (Online)
0975-2331 (Print)

Submit Article

Terminalia arjuna and Medicinal Properties: A Natural Product Source

Author(s): Aayush K. Ramraje, Hemangi R. Patil, Bhupendra M. Mahale, Akshata M. Girase, Ghanshyam M. Chavan

Email(s): Email ID Not Available

DOI: 10.52711/0975-4385.2026.00059

Address: Aayush K. Ramraje1, Hemangi R. Patil2, Bhupendra M. Mahale3, Akshata M. Girase4, Ghanshyam M. Chavan5
1Research Scholar, Dr. Babasaheb Ambedkar Technological University, Lonere, Raigad, Maharashtra, SVS's Dadasaheb Rawal Pharmacy College, Dondaicha - 425408 Maharashtra, India.
2Research Scholar, Dr. Babasaheb Ambedkar Technological University, Lonere, Raigad, Maharashtra, SVS's Dadasaheb Rawal Pharmacy College, Dondaicha - 425408 Maharashtra, India.
3Assistant Professor Department of Pharmaceutics P.S.G.V.P. Mandal’s College of Pharmacy, Shahada, Dist. Nandurbar Affiliated with KBCNMU Jalgaon, Maharashtra, India
4Assistant Professor, Pharmaceutical Quality Assurance. Babasaheb Ambedkar Technological University, Lonere, Raigad, MH, India.
5Principal, SVS’s Dadasaheb Rawal Pharmacy College Mandal – Dondaicha, 425408 Maharashtra, India.
*Corresponding Author

Published In: Volume - 18, Issue - 4, Year - 2026

View HTML

Purchase PDF

ABSTRACT:
Terminalia arjuna (Roxb.) Wight and Arn., commonly known as Arjuna, is a prominent medicinal tree belonging to the family Combretaceae and has been extensively utilized in traditional Ayurvedic medicine for centuries. The present review provides a comprehensive overview of the botanical characteristics, phytochemical composition, ethnomedicinal applications, and pharmacological properties of T. arjuna. Various parts of the plant, particularly the bark, contain a rich diversity of bioactive constituents, including triterpenoids, glycosides, flavonoids, tannins, phenolic compounds, and essential minerals, which contribute to its therapeutic potential. Numerous experimental and clinical studies have demonstrated its cardioprotective, antioxidant, anti-inflammatory, antimicrobial, antihyperlipidemic, antidiabetic, hepatoprotective, antiviral, wound-healing, and anticancer activities. The cardioprotective effects of T. arjuna have received significant scientific attention due to its ability to improve cardiac function, regulate blood pressure, reduce oxidative stress, and protect against myocardial damage. Furthermore, its antioxidant and anti-inflammatory properties play a crucial role in mitigating chronic diseases associated with oxidative stress. Traditional ethnomedicinal uses of T. arjuna for the management of cardiovascular disorders, skin diseases, fractures, asthma, and metabolic disorders are increasingly supported by modern pharmacological evidence. Despite its extensive therapeutic applications, further investigations are required to elucidate precise molecular mechanisms, establish standardized formulations, and conduct large-scale clinical trials to validate its efficacy and safety. Overall, Terminalia arjuna represents a valuable natural source of bioactive compounds with significant potential for the development of novel therapeutic agents and evidence-based phytopharmaceutical products

Keywords:

Cite this article:
Aayush K. Ramraje, Hemangi R. Patil, Bhupendra M. Mahale, Akshata M. Girase, Ghanshyam M. Chavan. Terminalia arjuna and Medicinal Properties: A Natural Product Source. Research Journal of Pharmacognosy and Phytochemistry. 2026; 18(4):413-0. doi: 10.52711/0975-4385.2026.00059

Cite(Electronic):
Aayush K. Ramraje, Hemangi R. Patil, Bhupendra M. Mahale, Akshata M. Girase, Ghanshyam M. Chavan. Terminalia arjuna and Medicinal Properties: A Natural Product Source. Research Journal of Pharmacognosy and Phytochemistry. 2026; 18(4):413-0. doi: 10.52711/0975-4385.2026.00059 Available on: https://www.rjpponline.org/AbstractView.aspx?PID=2026-18-4-15

REFERENCES:
1. D. Kapoor, R. Vijayvergiya, V. Dhawan, J Ethnopharmacol. 2014; 155; 1029.
2. S. Khalil. National Board of Examination; New Delhi, India: 2005.
3. T. Honda, T.N Murae, T. Suzuki, T. Takahashi. Chemical and Pharmaceutical Bulletin; 1976; 24; 178.
4. A.S.R. Anjaneyulu, A.V.R. Prasad, Phytochemistry. 1983; 22; 993.
5. en T, Samanta SK. Medicinal Plants, Human Health and Biodiversity: A Broad Review. In: Mukherjee J, editor. Biotechnological Applications of Biodiversity [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014 [cited 2021 Aug 25]: 59–110. Available: http://link.springer.com/10.1007/ 10_2014_273.
6. Varghese A, N. Pandita, R.S. Gaud. Indian J Pharm Sci. 2014; 76: 138.
7. V. Jain, A. Poonia, R.P. Agarwal, R.B. Panwar, D.K. Kochar, S.N. Mishra. Indian Med Gaz. 1992; 36: 56.
8. P.U. Kumar, P. Adhikari, P. Pereira, P. Bhat, J Assoc Physicians India. 1999; 47: 685
9. Dwivedi S, Chopra D. Revisiting Terminalia arjuna – An Ancient Cardiovascular Drug. J Tradit Complement Med. 2014; 4(4): 224–31.
10. Pandey AK. Mandal AK. Sustainable Harvesting of Terminalia arjuna (Roxb.) Wight and Arnot (Arjuna) and Litsea glutinosa (Lour.) Robinson (Maida) Bark in Central India. Journal of Sustainable Forestry. 2012; 31: 294-309. https://doi.org/10.1080/10549811.2011.583865
11. Warrier PK. Indian medicinal plants: a compendium of 500 species. Orient Blackswan. 1993.
12. Dhingra V, Dhingra S, Singla A. Forensic and pharmacognostic studies of the Terminalia arjuna Bark. Egyptian Journal of Forensic Sciences. 2013; 3(1): 15-9.
13. Petronelli A, Pannitteri G, Testa U. Triterpenoids as new promising anticancer drugs. Anticancer Drugs. 2009; 20(10): 880–92.
14. Ali A, Kaur G, Hamid H, Abdullah T, Ali M, Niwa M, et al. Terminoside A, a new triterpene glycoside from the bark of Terminalia arjuna inhibits nitric oxide production in murine macrophages. J Asian Nat Prod Res. 2003; 5(2): 137–42.
15. Cock IE. The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae). Inflammopharmacology. 2015; 23: 203-229. https://doi.org/10.1007/s10787-015-0246-z.
16. Padma M. Parrakh. Terminalia arjuna (Roxb.) Wt. and Arn.: a review. IJP International Journal of Pharmacology. 2010; 6: 515- 534.
17. Sivalokanathan S, Ilayaraja M, Balasubramanian MP. Antioxidant activity of Terminalia arjuna bark extract on Nnitrosodiethylamine induced hepatocellular carcinoma in rats. Molecular and Cellular Biochemistry. 2006; 281:87-93. https://doi.org/10.1007/s11010-006-0433-8.
18. Soni N. Singh VK. Efficacy and advancement of Terminalia arjuna in Indian Herbal Drug Research: A Review. Trends in Applied Sciences. 2019; 14: 233-242. 10.3923/tasr.2019.233.242.
19. Pandey AK. Mandal AK. Sustainable Harvesting of Terminalia arjuna (Roxb.) Wight and Arnot (Arjuna) and Litsea glutinosa (Lour.) Robinson (Maida) Bark in Central India. Journal of Sustainable Forestry. 2012; 31: 294-309. https://doi.org/10.1080/10549811.2011.583865.
20. Soni N. Singh VK. Efficacy and advancement of Terminalia arjuna in Indian Herbal Drug Research: A Review. Trends in Applied Sciences. 2019; 14:233-242. 10.3923/tasr.2019.233.242.
21. Morshed MA. Uddin A. Rahman A. Hasan T. Roy S. Amin AA. et al. In vitro antimicrobial and cytotoxicity screening of Terminalia arjuna ethanol extract. International Journal of Biosciences. 2011; 1: 31-38.
22. Chaudhari UM. Mengi S. Evaluation of phytoconstituents of Terminalia arjuna for wound healing activity in rats. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2006; 20: 799-805. https://doi.org/10.1002/ptr.1857.https://doi.org/10.1002/ptr.1857.https://doi.org/10.1002/ptr.1857.
23. Khan ZH. Faruquee HM. Shaik MM. Phytochemistry and pharmacological potential of Terminalia arjuna L. Medicinal Plant Research. 2013; 3:70-77. 10.5376/mpr.2013.03.0010.
24. Scassellati S. Forzolini G. Villarini LM. Moretti LM. Marcarelli LM. Pasquini R. et al. Antigenotoxic properties of Terminalia arjuna bark extracts. Journal Environment Pathology Toxicology Oncology: official organ of the Int Soc Environ Toxicol Cancer. 1999; 18: 119-125.
25. Morshed MA. Uddin A. Rahman A. Hasan T. Roy S. Amin AA. et al. In vitro antimicrobial and cytotoxicity screening of Terminalia arjuna ethanol extract. International Journal of Biosciences. 2011; 1: 31-38.
26. Dwivedi S. Udupa N. Terminalia arjuna: pharmacognosy, phytochemistry, pharmacology and clinical use. A review. Fitoterapia. 1989; 60: 413-420. https://www.cabdirect.org/cabdirect/abstract/19900394254.https://www.cabdirect.org/cabdirect/abstract/19900394254.https://www.cabdirect.org/cabdirect/abstract/19900394254.
27. Kandil FE. Nassar MI. A tannin anti-cancer promotor from Terminalia arjuna. Phytochemistry. 1998; 47: 1567-1568. https://doi.org/10.1016/S0031-9422(97)01078-9.https://doi.org/10.1016/S0031-9422(97)01078-9.https://doi.org/10.1016/S0031-9422(97)01078-9.
28. Singh V. Bharadwaj A. Wahi N. Phytochemical analysis and in vitro antimicrobial activities of Terminalia arjuna leaf, bark and fruit extracts in different solvents. Current Trends in Biotechnology and Pharmacy. 2018; 12: 286-294.
29. Moulisha B. Kumar GA. Kanti HP. Anti-leishmanial and anticancer activities of a pentacyclic triterpenoid isolated from the leaves of T. arjuna Combretaceae. Tropical Journal of Pharmaceutical and Research. 2010; 9: 135-40. 10.4314/tjpr.v9i2.53700.
30. Singh S. Shukla N. Bhowmick M. Rathi J. Evaluation of Antidiabetic activity of Terminalia arjuna root extract in Alloxan induced diabetic rats. Journal of Biomedical Pharmaceutiacl Research. 2019; 8:20-29.
31. Dwivedi S. Udupa N. Terminalia arjuna: pharmacognosy, phytochemistry, pharmacology and clinical use. A review. Fitoterapia. 1989; 60: 413-420. https://www.cabdirect.org/cabdirect/abstract/19900394254.
32. Scassellati S. Forzolini G. Villarini LM. Moretti LM. Marcarelli LM. Pasquini R. et al. Antigenotoxic properties of Terminalia arjuna bark extracts. Journal Environment Pathology Toxicology Oncology: official organ of the Int Soc Environ Toxicol Cancer. 1999; 18: 119-125.
33. Kandil FE. Nassar MI. A tannin anti-cancer promotor from Terminalia arjuna. Phytochemistry. 1998; 47: 1567-1568. https://doi.org/10.1016/S0031-9422(97)01078-9https://doi.org/10.1016/S0031-9422(97)01078-9.
34. Singh V. Bharadwaj A. Wahi N. Phytochemical analysis and in vitro antimicrobial activities of Terminalia arjuna leaf, bark and fruit extracts in different solvents. Current Trends in Biotechnology and Pharmacy. 2018; 12: 286-294.
35. Moulisha B. Kumar GA. Kanti HP. Anti-leishmanial and anticancer activities of a pentacyclic triterpenoid isolated from the leaves of T. arjuna Combretaceae. Tropical Journal of Pharmaceutical and Research. 2010; 9: 135-40. 10.4314/tjpr.v9i2.53700.
36. Moulisha B. Kumar GA. Kanti HP. Anti-leishmanial and anticancer activities of a pentacyclic triterpenoid isolated from the leaves of T. arjuna Combretaceae. Tropical Journal of Pharmaceutical and Research. 2010; 9: 135-40. 10.4314/tjpr.v9i2.53700.
37. Morshed MA. Uddin A. Rahman A. Hasan T. Roy S. Amin AA. et al. In vitro antimicrobial and cytotoxicity screening of Terminalia arjuna ethanol extract. International Journal of Biosciences. 2011; 1: 31-38.
38. Kandil FE. Nassar MI. A tannin anti-cancer promotor from Terminalia arjuna. Phytochemistry. 1998; 47: 1567-1568. https://doi.org/10.1016/S0031-9422(97)01078-9.
39. Singh S. Shukla N. Bhowmick M. Rathi J. Evaluation of Antidiabetic activity of Terminalia arjuna root extract in Alloxan induced diabetic rats. Journal of Biomedical Pharmaceutiacl Research. 2019; 8: 20-29.
40. Kumar SS. Melchias G. Ravikumar P. Chandrasekar R. Kumaravel P. Bioinspired synthesis of silver nanoparticles using Euphorbia hirta leaf extracts and their antibacterial activity. Asian Journal of Pharmaceutical Research. 2014; 4(1): 39-43.
41. Varghese A. Savai J. Pandita N. Gaud R. In vitro modulatory effects of Terminalia arjuna, arjunic acid, arjunetin and arjungenin on CYP3A4, CYP2D6 and CYP2C9 enzyme activity in human liver microsomes. Toxicology Reports. 2015; 2: 806- 816. https://doi.org/10.1016/j.toxrep.2015.02.008.
42. Ahmad MS. Ahmad S. Gautam B. Arshad M. Afzal M. Terminalia arjuna, a herbal remedy against environmental carcinogenicity: an in vitro and in vivo study. Egyptian Journal of Medical Human Genetics. 2014; 15: 61-68. https://www.ajol.info/index.php/ejhg/article/view/100847.
43. Wadhai M. Ayate D. Ujjainkar VV. Estimation of tannin content in leaves, bark and fruits of Terminalia arjuna Roxb. International Journal of Farm Sciences. 2019; 9: 61-63. 10.5958/2250- 0499.2019.00004.1.
44. Dwivedi S. Udupa N. Terminalia arjuna: pharmacognosy, phytochemistry, pharmacology and clinical use. A review. Fitoterapia. 1989; 60: 413-420. https://www.cabdirect.org/cabdirect/abstract/19900394254.
45. Verma N. Vinayak M. Effect of Terminalia arjuna on antioxidant defense system in cancer. Molecular Biology Reports. 2009; 36: 159-64. https://doi.org/10.1007/s11033-008-9279-3.
46. Hemalatha T. Pulavendran S. Balachandran C. Manohar BM. Puvanakrishnan R. Arjunolic acid: a novel phytomedicine with multifunctional therapeutic applications. Indian J Exp Biol 2010; 48: 238-47. http://nopr.niscair.res.in/handle/123456789/7399.
47. Anand U. Jacobo-Herrera N. Altemimi A. Lakhssassi N. A comprehensive review on medicinal plants as antimicrobial therapeutics: potential avenues of biocompatible drug discovery. Metabolites. 2019; 9: 258. https://doi.org/10.3390/metabo 9110258.
48. Aneja KR. Sharma C. Joshi R. Antimicrobial activity of Terminalia arjuna Wight and Arn.: An ethnomedicinal plant against pathogens causing ear infection. Brazilian Journal of Otorhinolaryngology. 2012; 78: 68-74.
49. Ramya S. Kalaivani T. Rajasekaran C. Jepachanderamohan P. Alaguchamy N. Kalayansundaram M et al. antimicrobial activity of aqueous extracts of bark, root, leaves and fruits of Terminalia arjuna Wight and Arn. Ethnobotanical leaflets. 2008; 2008: 1192- 1197. https://opensiuc.lib.siu.edu/ebl/vol2008/iss1/158.
50. J.Singh, V. Perumal, U. Singh, D.K. Tripathi, S. Sharma, Current Nanoscience. 2022; 18(6): 743.
51. Upadhyay B, Singh KP, Kumar A. Ethnoveterinary uses and informantsconsensus factor of medicinal plants of Sariska region, Rajasthan, India.J Ethnopharmacol. 2011; 133: 14e25.
52. S. Dwivedi, J.P. Chansouria, P.N. Somani, K.N. Udupa, Altern Med, 1989; 3: 115.
53. Ram, P. Lauria, R. Gupta, P. Kumar, V.N. Sharma, J Ethnopharmacol. 1997; 55: 165.
54. Bhatia J, Bhattacharya SK, Mahajan P, Dwivedi S. Effect of Terminalia arjuna on coronary flow—an experimental study (Abstract). IndianJournal of Pharmacology 1998; 30: 118- 120.
55. Bhatia J, Bhattacharya SK, Mahajan P. Dwivedi S. Effect of Terminalia arjuna oncoronary flow—an experimental study (Abstract). IndianJournal of Pharmacology. 1998; 30: 118- 120.
56. Singh DV, Gupta MM, Santha TR, Kumar S, Khanuja SPS. Antibacterial principles from the bark of Terminalia arjuna, Current Science. 2008; 94: 1- 10.
57. Srivastava, A.K., Kumar, D., Pandey, J.P., Kumar, V. and Prasad, B.C. Horticulture and tasar flora: status, scope and potentialutilization. HortFlora Res. Spectrum. 2012; 1(1): 13-16.
58. Charak Samhita. Vaidya Jadavaji Trikamji Acharya, Chakrapani with commentary, Sutra Bombay: Nirnaya Sagar Press, India. 1941: 173 (reprinted by Chaukhamba Sanskrit Sansthan, Varanasi, India, 1984).
59. Summer R, Sigler R, ShelhamerJH, Kaliner M. Effect of infused histamine on the asthmatic and normal subject; comparison of skin test responses. J Allergy Clin Immunol. 1981; 67: 456.
60. Akah PA, Ezike AC, Nwafor SV, Ololiad CO, Enwerem NM. Evaluation of asthmatic property of astasia gangetic leaf extract. J Ethnopharmacol. 2003; 89: 25.